Fibrinolytic changes in pregnant women on highly active antiretroviral therapy

References

1. ↵
   1. Lau G

   (2002) Are maternal deaths on the ascent in Singapore? A review of maternal mortality as reflected by coronial casework from 1990 to 1999. Ann Acad Med Singapore 31:261–272.

   OpenUrlPubMed
2. ↵
   1. Alan HD,
   2. Lauren NC

   1. Koos JB,
   2. Moore JP

   (2003) in Current obstetric and gynaecologic diagnosis and treatment, Maternal Physiology during pregnancy, eds Alan HD, Lauren NC (McGraw Hill Companies, New York (NY)), 9th ed, pp 154–162.
3. ↵
   1. Akinsete I,
   2. Uyanwah PO

   (1989) The fibrinolytic enzyme system in pregnancy in Nigerians. Afr J Med Sci 18:89–93.

   OpenUrl
4. ↵
   1. Adediran IA,
   2. Durosinmi MA,
   3. Ogunniyi SO,
   4. Akinda NO,
   5. Akanmu AS

   (1999) Haemostatic parameters in normal pregnant Nigerian and Nigerians with hypertensive disorder of pregnancy. Niger Postgr Med T 6:49–52.

   OpenUrl
5. ↵
   1. Jourdain G,
   2. Ngo-Giang-Huong N,
   3. Le Coeur S,
   4. Bowonwatanuwong G,
   5. Kantypong P

   (2004) Intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 51:229–240.

   OpenUrl
6. ↵
   1. Lieve BP,
   2. Shafer LA,
   3. Mayanja BN,
   4. Whitworth JA,
   5. Grosskurth H

   (2007) Effect of pregnancy on HIV disease progression and survival among women in rural Uganda. Trop Med Int Health 12:920–928.

   OpenUrlCrossRefPubMedWeb of Science
7. ↵
   1. Hadigan C,
   2. Meigs JB,
   3. Rabe J,
   4. D’Agostino RB,
   5. Wilson PW,
   6. Lipinska I,
   7. et al.

   (2001) Increased PA1-1 and tPA antigen levels, are reduced, with metformin therapy in HIV-infected patients with fat redistribution and insulin resistance. T. Clin Endocrinol Metab 86:939–943.

   OpenUrl
8. ↵
   1. Andrade ACO,
   2. Cotter BR

   (2006) Endothelial Function and Vascular diseases in HIV infected patient. Braz J Infect Dis 10:139–145.

   OpenUrlPubMed
9. ↵
   1. Barbaro G

   (2003) HIV infection, highly active antiretroviral therapy and the cardiovascular system. Cardiovascular Res 111:389–397.

   OpenUrl
10. ↵
    1. Carr A,
    2. Samaras K,
    3. Thorisdottir A,
    4. Kauffman GR,
    5. Chisolm DJ,
    6. Cooper DA

    (1999) Diagnosis, prediction and natural course of HIV-1 protease-inhibitor associated lipodystrophy, hyperlipidemia, and diabetes mellitus;a cohort study. Lancet 353:2093–2099.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Hadigan C,
    2. Miller K,
    3. Corcoran C,
    4. Anderson E,
    5. Basgoz N,
    6. Grinspoon S

    (1999) Fasting hyperinsulinemia and changes in regional body composition in HIV-infected women. J Clin Endocrino Metab 84:1932–1937.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    1. Ingram GI

    (1961) A suggested schedule for the rapid investigation of acute haemostatic failure. J Clin Pathol 14:356–360.

    OpenUrlAbstract/FREE Full Text
13. ↵
    1. Reid A,
    2. Ugwu AC

    (1989) A simple technique of rapid determination of plasma and whole blood viscosity. Nig J Physiol Sci 3:45–48.

    OpenUrl
14. ↵
    1. Omoigberale AI,
    2. Abiodun PO,
    3. Famodu AA

    (2005) Fibrinolytic activity in children with Plasmodium falciparum Malaria. East Afr Med J 82:104–106.

    OpenUrl
15. ↵
    1. Tang YW

    1. Zha BS,
    2. Studer EJ,
    3. Zha H,
    4. Hylemon PB,
    5. Pandak W,
    6. Zhou H

    (2011) in Recent Translational Research in HIV/AIDS, Highly active antiretroviral therapy, ed Tang YW (InTech, Rijeka (HR)).
16. ↵
    1. Moyle G

    (2002) Anaemia in persons with HIV infection prognostic marker and contributor to morbidity. AIDS Rev 4:13–20.

    OpenUrlPubMed
17. ↵
    1. Mchedlishvili G,
    2. Varazashvili M,
    3. Gobejishvili L

    (2002) Local RBC aggregation disturbing blood fluidity and causing stasis in microvessels. Clin Hemorheol Microcirc 26:99–106.

    OpenUrlAbstract/FREE Full Text
18. ↵
    1. Kim A,
    2. Dadgostar H,
    3. Holland GN,
    4. Wenby R,
    5. Yu F,
    6. Terry BG,
    7. et al.

    (2006) Hemorheologic abnormalities with HIV infection: altered erythrocyte aggregation and deformability. Invest Opthalmol Vis Sci 47:3927–3932.

    OpenUrlAbstract/FREE Full Text
19. ↵
    1. Wilkins EG,
    2. Fraser I,
    3. Barnes A,
    4. Khow S,
    5. Hamour A

    (1992) Plasma viscosity in HIV infection. Int Cont AIDs 8:143.

    OpenUrl